Unknown

Dataset Information

Comparative molecular characterization of typical and exceptional responders in glioblastoma.


ABSTRACT: Glioblastoma (GBM) is the most common and the deadliest type of primary brain tumor, with a median survival time of only 15 months despite aggressive treatment. Although most patients have an extremely poor prognosis, a relatively small number of patients survive far beyond the median survival time. Investigation of these exceptional responders has sparked a great deal of interest and is becoming an important focus in the field of cancer research. To investigate the molecular differences between typical and exceptional responders in GBM, comparative analyses of somatic mutations, copy number, methylation, and gene expression datasets from The Cancer Genome Atlas were performed, and the results of these analyses were integrated via gene ontology and pathway analyses to assess the functional

SUBMITTER: Wipfler K 

PROVIDER: S-EPMC6033343 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature